Abasic CNA CPG
CPG for the incorporation of an abasic spacer at the 3' end of an oligonucleotide.
CPG for the incorporation of an abasic spacer at the 3' end of an oligonucleotide.
Aminopropyl CPG for base or modifier functionalisation.
CPG used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
CPG for incorporation of a C16 spacer at the 3' end of an oligonucleotide.
CPG for incorporation of a locked nucleic acid T analogue at the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyuridine base into the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyinosine base into the 3' end of an oligonucleotide.
CPG for incorporation of a C2 spacer at the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyuridine base into the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyinosine base into the 3' end of an oligonucleotide.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |